Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Iskratsch, T
Primary Identification Clinical Specifications Injection - A sterile preparation intended for parenteral use
doi: 10.1007/s00726-012-1301-3 134 WeiC.HeT.WanX.LiuS.DongY.QuY
502 As for the risk of recurrence among women who attempted to conceive, a recent prospective trial indicated that among HR+ early breast cancer patients, temporary interruption of endocrine therapy to attempt pregnancy would not induce a higher rate of breast cancer recurrence (8.9%) compared to the control group (9.2%)
Laboratory studies have explored its role in: Cell culture and proliferation assays Molecular binding and receptor interaction studies Tissue regeneration and wound healing models Biochemical pathway analysis Pharmacokinetic and stability profiling Note: GHK-Cu sold by CoreVionRX is intended strictly for research purposes
US$ 27.14
US$ 28.85
US$ 22.11
US$ 27.17
